Full-Time

Contract Toxicologist

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • DVM or PhD in a relevant field (Toxicology, Pharmacology) with at least 5+ years of post-graduate drug development experience.
  • Experience in developing and overseeing toxicology programs to support early and later stage drug development.
  • Ability to oversee and advance development candidates in multiple programs simultaneously.
  • Knowledge of relevant ICH & FDA guidance and regulations that are relevant for the strategic planning and conduct of safety studies to support first-in-human (FIH) testing.
  • Demonstrated ability to apply critical thinking to solve complex problems to craft customized preclinical strategies for small molecule discovery programs.
  • Experience in authoring of preclinical safety section in regulatory filings such as INDs/CTAs.
  • Ability to critically evaluate written toxicology documents for overall quality and acceptability of scientific interpretation.
  • Ability to oversee CRO interface, as appropriate, to deliver high quality, cost-effective, and timely safety assessment.
  • Outstanding interpersonal skills and oral and written communication skills.
  • Ability and experience in managing a team in a different time zone.
  • Board certification in toxicology is highly desirable.
Responsibilities
  • Execute on our toxicology efforts to support our preclinical programs.
  • Ability to communicate and execute studies with CRO organization overseas.
  • Provide toxicology expertise and strategic guidance to cross-functional project teams and senior management, including toxicology study results and potential impact of toxicology findings on programs.
  • Serve as a member of program teams and collaborate with internal and external research partners including preclinical pharmacology, DMPK, and translational sciences to advance drug candidates from discovery to the clinic.
  • Provide internal expertise to understand the mechanisms of toxicity, propose solutions for mitigation and back-up strategies.
  • Design and direct nonclinical safety studies, including the evaluation and interpretation of safety pharmacology, toxicology, and toxicokinetic information.
  • Develop optimal CRO network for toxicology studies, build and maintain effective vendor relationships.
  • Serve as study monitor and sponsor representative for outsourced studies.
  • Draft, review, and provide feedback on study protocols, reports, and other documentation as needed.
  • Represent Cellarity in Regulatory Agency interactions for toxicology-related issues.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.

Help us improve and share your feedback! Did you find this helpful?